Virtual worlds for real hands: MS patients test mixed reality therapy
NCT ID NCT06968676
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using mixed reality (a blend of real and virtual environments) can improve hand strength, coordination, and quality of life in people with multiple sclerosis. Thirty participants will either receive standard physiotherapy or standard therapy plus mixed reality exercises using Meta Quest 3 glasses. The trial lasts 10 weeks with a one-month follow-up.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mixed reality exercises using Meta Quest 3.0 glasses combined with conventional physiotherapy
- What this could lead to
- If it works, this could offer a new, engaging way to improve hand strength and daily function for people with multiple sclerosis.
- What could go wrong
- This is a small, early-stage trial with only 30 participants. The mixed reality approach is new for MS, so results may not be generalizable or show clear benefit over standard therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: -\>18 years of age. * Diagnosis of MS according to McDonald criteria (53) with a time of evolution longer than two years. * Assessment on the Kurtzke Multiple Sclerosis Disability Status Scale (EDSS) with a score between 2. 0 (minimal disability in one section of the FS (at least one with a score of 2).) to 7.0 (unable to walk more than a few steps, even with assistance, basically confined to wheelchair and able to transfer from wheelchair to another place, or can manage to go to the toilet for 12 hours a day) . * Stable medical treatment for at least six months prior to surgery. * Upper extremity muscle tone no greater than 2 points (moderate hypertonia, increased muscle tone during most of the arc of motion, but can passively move the affected part with ease) on the modified Ashworth Scale. * Muscle balance equal to or greater than 3 in the upper extremity. * Score less than or equal to 4 points on the "Pyramidal Function" section of the EDSS functional scale. * Absence of cognitive impairment, with ability to understand instructions and score equal to or greater than 24 on the Minimental Test. A- score equal to or less than 2 points on the "Mental Functions" section of the EDSS. Exclusion Criteria: * Diagnosis of a neurological disease or musculoskeletal disorder other than MS. * Diagnosis of a cardiovascular, respiratory or metabolic disease or other conditions that may interfere with this study. * Having suffered an exacerbation or hospitalization in the last 3 months before starting the assessment protocol, or during the therapeutic intervention process. * Having received a course of steroids, intravenous or oral, 6 months prior to the start of the assessment protocol and within the intervention period of the study duration. * Having received treatment with botulinum toxin in the 6 months prior to the start of the study. * A score higher than 2 points on the modified Ashworth scale. * Cognitive or language impairment that prevents adequate communication or comprehension. * The presence of visual disturbances not corrected by ocular devices; or a history of photosensitive epilepsy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Asociación de Leganés de Esclerosis Múltiple
RECRUITINGLeganés, Madrid, 28918, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise rebuild muscle and balance in MS?
- Can diet ease the crushing fatigue of multiple sclerosis?
- One-Time CAR-T infusion tested against progressive MS
- Can PET scans reveal hidden brain inflammation in MS?
- Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
- Migraines and tension headaches may be hidden companions to multiple sclerosis